How we measure 'reads'
A 'read' is counted each time someone views a publication summary (such as the title, abstract, and list of authors), clicks on a figure, or views or downloads the full-text. Learn more
I am coordinating a panel survey on university freshmen which is a part of the WHO World Mental Health Surveys International College Student Project (WMH-ICS). Additionally, I am conducting a RCT of an unguided ICBT in university student with social anxiety disorder which evaluates the efficacy and cost-effectiveness. Besides, I am interested in health economic evaluations alongside RCTs from several perspectives. My first papers will hopefully be published at the beginning of the year 2018.
Systematically assess and interpret evidence regarding the cost-effectivness of internet- and mobile-based interventions.
The primary aim of the StudiCare Panel is to screen for mental health, behavioral and academic problems in order to determine the current prevalence and incidence of mental health disorders. Based on new data we intend to identify distinct student characteristics at the start of their academic career which can serve as predictive risk or protective factors for mental health disorders. The second aim is the identification of potential predictors for the use of mental health services among university students. Therefore, magnitude of service use, its predictors and possible barriers are identified.
The study is a two arm randomized controlled trial in which 200 university students with a primary diagnosis of SAD will be assigned randomly to either a wait-list control group or an intervention group (IG). The intervention consists of 9 sessions of an internet-based cognitive-behavioral treatment, which also includes a module on fear of positive evaluation. Guidance is delivered only on the basis of standardized automatic messages, consisting of positive reinforcements for session completion, reminders, and motivational messages in response to non-adherence. All participants will additionally have full access to treatment as usual. Diagnostic status will be assessed through Structured Clinical Interviews for DSM Disorders (SCID). Assessments will be completed at baseline, 10 weeks and 6 months follow-up. The primary outcome will be SAD symptoms at post-treatment, assessed via the Social Phobia Scale (SPS) and the Social Interaction Anxiety Scale (SIAS). Secondary outcomes will include diagnostic status, depression, quality of life and fear of positive evaluation. Cost-effectiveness will be evaluated from a societal and health provider perspective.